Copyright
©The Author(s) 2025.
World J Clin Pediatr. Dec 9, 2025; 14(4): 110374
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.110374
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.110374
Table 1 Tests to detect hypothalamic-pituitary-adrenal axis integrity
| Test name | Methods | Expected result |
| Serum cortisol level | Measurement of early morning between 7:00 am to 9:00 am | Normal: Serum cortisol level ≥ 18 μg/dL. Insufficient: < 3 μg/dL. Indeterminate: 3-18 μg/dL |
| Insulin tolerance testing | Insulin (0.05 0.15 U/kg IV). Serum measurements of cortisol at 0, 30, 60 minutes | Normal: Peak cortisol ≥ 18 μg/dL. Insufficient: Serum cortisol level < 18 μg/dL |
| Metyrapone test | Metyrapone 30 mg/kg administered at midnight and measurement of serum cortisol and 11-deoxycortisol at 8:00 the next morning | Serum cortisol < 7 μg/dL confirms enzymatic blockade. Normal: Serum 11-deoxycortisol > 7 μg/dL. Insufficient: Serum 11-deoxycortisol, 7 μg/dL |
| ACTH stimulation test | Synthetic ACTH (250 μg IV or IM or 1 μg IV). Serum measurements of cortisol at 0, 30, 60 minutes | Normal: Serum cortisol level ≥ 18 μg/dL. Insufficient: Serum cortisol < 18 μg/dL |
Table 2 Studies evaluating hypothalamic-pituitary-adrenal axis suppression in children with nephrotic syndrome
| Ref. | Patient characteristics | Sample size | Method of evaluation | HPA suppression (%) | Conclusion of the study |
| Leisti et al[33], 1983 | SSNS | 47 | Two-hour ACTH test | 51 | HPA axis suppression increased relapse risk. Cortisol substitution may prevent relapse in severe suppression, but not in moderate cases |
| Abeyagunawardena et al[40], 2007 | SSNS with LTAD | 32 | LDST, Synacthen 0.5 mg | 62.5 | SSNS on LTAD risk HPA suppression. Assess HPA suppression via modified LDST. HPA suppression in SSNS on LTAD increases relapse risk |
| Mantan et al[41], 2018 | SSNS on LTAD | 70 | Morning serum cortisol levels | 40 | NS on prolonged LTAD should screened for HPA suppression using single morning cortisol, confirmed by LDST |
| Abu Bakar et al[9], 2020 | SSNS, off steroid for 4–6 weeks | 37 | LDST, Synacthen 0.5 μg/m2 | 35 | HPA suppression can be missed without proper screening. Normal early morning cortisol alone can’t rule out HPA suppression. LDST is useful, especially in children under 5 years |
| Khan et al[17], 2023 | First episode NS, on steroid | 60 | Synacthen test | 100 in divided dose. 83 in single dose | Single and divided-dose prednisolone equally effective for remission. Single-dose causes less HPA axis suppression. Single-dose delays time to first relapse |
| M et al[42], 2025 | First episode. SSNS, off steroid 4 weeks | 80 | Early morning baseline and ACTH stimulation | 32.5 | Around 66% of children with mild NS showed HPA recovery within 1–6 months post-steroids. Duration since cessation and basal cortisol independently predicted recovery |
| Krishna et al[43], 2024 | SSNS (52%), SRNS (48%), off steroid (11.5%) and/or LTAD (88.5%) | 52 | Baseline and ACTH stimulation | Baseline: 50%. Post ACTH stimulation: 60% | Adrenal insufficiency was common in children with nephrotic syndrome. Steroid dose > 0.22 mg/kg/day (alternate days) predicted adrenocortical suppression |
- Citation: Sarkar S, Abeyagunawardena AS, Sinha R. Impact of glucocorticoid therapy on hypothalamic-pituitary-adrenal axis function in pediatric nephrotic syndrome: A narrative review. World J Clin Pediatr 2025; 14(4): 110374
- URL: https://www.wjgnet.com/2219-2808/full/v14/i4/110374.htm
- DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.110374
